New DEA rule leaves patients in pain

Thousands of Americans suffering from chronic pain rely on those drugs to function. The new regulations mean these individuals now face greater difficulties getting their needed medication. In a recent article, the Washington Post reported that the rule is taking a particularly difficult toll on veterans suffering from battlefield injuries like missing limbs and PTSD…

But those in search of pain medications aren’t the only ones who will bear the costs. Since doctors’ offices must now contend with more patients, more appointments, and more paperwork, these changes are likely to increase wait times for all patients.

The debate over drug use in the United States is ongoing. Since the war on drugs began in the 1970s, the U.S. government has played a unending game of “whack-a-mole,” restricting one drug, only to have another drug take its place. Those using prescription painkillers to get high will find other alternatives. The rest of us, however, are stuck with more time at the doctor’s office, higher medical costs, and more difficulty getting medications we need. Those who pay the highest price are the thousands of American men and women who, thanks to the new restrictions, will face an even greater struggle to manage their pain.

Under comments:

Jared Owen ebola131 • 2 days ago
Talks about a man smuggling in something to treat his wife’s cancer obviously because he can’t afford her treatment how often do you see stories similar to that in socialist not for profit healthcare facilities? In my opinion.

The Drug Enforcement Administration (DEA) is issuing this notice to inform individuals and businesses handling safrole and essential oils rich in safrole, such as sassafras oil, “brown” camphor oil 1.070, also referred to as Chinese sassafras oil, that they are sometimes used in the manufacture of MDMA…

It is unlawful for any person knowingly or intentionally to possess or distribute safrole, knowing, or having reasonable cause to believe, the safrole will be used to manufacture MDMA.

The Drug Enforcement Administration thanks you for your cooperation in this matter.

Safrole is a chemical more properly called 5-(2-propenyl)-1,3-benzodioxole, it is a Schedule I chemical and requires a DEA permit for purchase. What you are looking for is Sassafras Essential Oil. A very good quality sassafras oil contains up to 98% safrole, but 75-80% is much more common…

A Schedule I chemical just because sometimes it’s used in the making of ecstasy.  Jesus.

One thought on “New DEA rule leaves patients in pain

If you don't comment, I'll just assume you agree with me

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s